C
CARTESIAN THERAPEUTICS INC.
NASDAQ: RNAC (Cartesian Therapeutics, Inc.)
Last update: 19 hours ago6.49
-0.26 (-3.85%)
| Previous Close | 6.75 |
| Volume | 78,798 |
| Price / Sales | 123.73 |
| 52 Weeks Range |
| Profit Margin | -112.11% |
| Operating Margin (TTM) | -1,989.91% |
| Diluted EPS (TTM) | 5.33 |
| Quarterly Revenue Growth (YOY) | -81.20% |
| Total Debt/Equity (MRQ) | 1,948.27% |
| Current Ratio (MRQ) | 12.34 |
| Operating Cash Flow (TTM) | -30.86 M |
| Levered Free Cash Flow (TTM) | -47.63 M |
| Return on Assets (TTM) | -7.55% |
| Return on Equity (TTM) | -7,029.26% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Cartesian Therapeutics, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | -4.0 |
| Relative Valuation | NA |
| Financial Health | -2.5 |
| Macro Environment | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | -0.27 |
Select this tab to load the latest available analysis.
|
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 59.96% |
| % Held by Institutions | 25.63% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Privium Fund Management B.V. | 30 Jun 2026 | 151,675 |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |